Irving Weissman, MD, director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine will receive the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for his pioneering work in stem cell and cancer biology, including the identification of blood-forming stem cells and their role in blood cancers, as well as the discovery of a “don’t eat me” signal on the surface of many cancer cells that protect them from being eliminated from the immune system.

Stanford Medicine News Center’s Krista Conger writes that Weissman is a professor of pathology and of developmental biology at the Stanford School of Medicine and is the director of the Ludwig Center for Cancer Stem Cell Research at Stanford. He will share the $500,000 prize with Bert Vogelstein, MD, who is the Clayton Professor of Oncology and Pathology at Johns Hopkins University’s Sidney Kimmel Cancer Center and the director of its Lustgarten Laboratory for Pancreatic Cancer Research.

The Albany Prize is funded by a $50 million gift from New York City philanthropist Morris Silverman. It has been awarded since 2001 to encourage and recognize extraordinary and sustained contributions to improving health care and promoting biomedical research with translational benefits for better patient care.

Source: Stanford Medicine News Center

Pin It on Pinterest